| AMPs | Antimicrobial peptides |
| ATP | Adenosine triphosphate |
| BM | Bone morphogenetic protein |
| CAMP | Cathelicidin antimicrobial peptide |
| CCR2 | C–C chemokine receptor type 2 |
| CCR6 | C–C chemokine receptor type 6 |
| CNV | Copy number variation |
| COPD | Chronic obstructive pulmonary disease |
| DAMPs | Damage-associated molecular patterns |
| DC | Dendritic cell |
| DUOX1 | Dual oxidase 1 |
| EGFR | Epidermal growth factor receptor |
| ELA2 | Neutrophil elastase 2 |
| FGF2 | Fibroblast growth factor |
| GEC | Gingival epithelial cell |
| HBEGF | Heparin binding EGF like growth factor |
| HER2 | Human epidermal growth factor receptor 2 |
| HGFs | Human gingival fibroblasts |
| HMGB1 | High mobility group box 1 |
| IDR | Innate defense regulator |
| IGF | Insulin like growth factor |
| IL-1α | Interleukin-1α |
| IL-33 | Interleukin-33 |
| JAK | Janus Kinase |
| LPS | Lipopolysaccharides |
| LTA | Lipoteichoic acid |
| MAPK | Mitogen-activated protein kinase |
| MIC | Minimum inhibitory concentration |
| MIP–3 | Macrophage inflammatory protein-3 alpha |
| MRGPRX2 | Mas-related G-protein coupled receptor member X2 |
| NETs | Neutrophil extracellular traps |
| NF-κB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| NOD2 | Nucleotide-binding oligomerization domain |
| OSCC | Oral squamous cell carcinoma |
| P2X7 | Purinoceptor 7 |
| SNP | Single nucleotide polymorphism |
| STAT | Signal transducer and activator of transcription |